Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
International Journal of Cancer
|
August 15, 1989
Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13
P J Russell, J Wass, R Lukeis, et al.
Genomics
|
May 15, 2001
A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1
F Watt, A Martorana, D E Brookes, et al.
The Prostate
|
May 27, 1999
Elevated expression of FGF-2 does not cause prostate cancer progression in LNCaP cells
P J Russell, S Bennett, A Joshua, et al.
Human Gene Therapy
|
August 7, 1998
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors
R Martiniello-Wilks, J Garcia-Aragon, M M Daja, et al.
Radiation Oncology Investigations
|
May 20, 1999
Heterogeneity of in vitro radiosensitivity in human bladder cancer cells
A R Barnetson, D Banasiak, R J Fisher, et al.
Molecular & General Genetics : MGG
|
January 1, 1984
Organization of the ribosomal ribonucleic acid genes in various wild-type strains and wild-collected strains of Neurospora
P J Russell, S Wagner, K D Rodland, et al.
Cancer Immunology, Immunotherapy : CII
|
September 28, 2004
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer
P J Russell, K T Ow, P N Tam, et al.
The Journal of Urology
|
May 26, 2016
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer
H Rhee, P Thomas, B Shepherd, et al.
Biochemical and Biophysical Research Communications
|
May 26, 2006
Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo
L A Perryman, J M Blair, E A Kingsley, et al.
Gene Therapy
|
September 3, 2004
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus
X Y Wang, R Martiniello-Wilks, J M Shaw, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
International Journal of Cancer
|
August 15, 1989
Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13
P J Russell, J Wass, R Lukeis, et al.
Genomics
|
May 15, 2001
A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1
F Watt, A Martorana, D E Brookes, et al.
The Prostate
|
May 27, 1999
Elevated expression of FGF-2 does not cause prostate cancer progression in LNCaP cells
P J Russell, S Bennett, A Joshua, et al.
Human Gene Therapy
|
August 7, 1998
In vivo gene therapy for prostate cancer: preclinical evaluation of two different enzyme-directed prodrug therapy systems delivered by identical adenovirus vectors
R Martiniello-Wilks, J Garcia-Aragon, M M Daja, et al.
Radiation Oncology Investigations
|
May 20, 1999
Heterogeneity of in vitro radiosensitivity in human bladder cancer cells
A R Barnetson, D Banasiak, R J Fisher, et al.
Molecular & General Genetics : MGG
|
January 1, 1984
Organization of the ribosomal ribonucleic acid genes in various wild-type strains and wild-collected strains of Neurospora
P J Russell, S Wagner, K D Rodland, et al.
Cancer Immunology, Immunotherapy : CII
|
September 28, 2004
Immunohistochemical characterisation of the monoclonal antibody BLCA-38 for the detection of prostate cancer
P J Russell, K T Ow, P N Tam, et al.
The Journal of Urology
|
May 26, 2016
Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer
H Rhee, P Thomas, B Shepherd, et al.
Biochemical and Biophysical Research Communications
|
May 26, 2006
Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo
L A Perryman, J M Blair, E A Kingsley, et al.
Gene Therapy
|
September 3, 2004
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus
X Y Wang, R Martiniello-Wilks, J M Shaw, et al.
Page
of 17